Reacción a "Reactions to the approval of lecanemab for the treatment of Alzheimer's patients in the US"

This really is remarkable news.  Certainly there are concerns about serious side effects and questions about the balance between clinical benefits and the overall costs of treatment.  Nevertheless, this decision badges Alzheimer’s disease as an illness which can potentially be treated or prevented, rather than simply endured.